Dietary intake of people with severe mental illness: Systematic review and meta-analysis

British Journal of Psychiatry

Volumn 214, Issue 5, 2019, Pages 251-259

  Teasdale, Scott B ^a   Ward, Philip B ^a   Samaras, Katherine ^a   Firth, Joseph ^b,f   Stubbs, Brendon ^c   Tripodi, Elise ^d   Burrows, Tracy L ^e  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b WESTERN SYDNEY UNIVERSITY   (Australia)

^c SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^d SOUTH EASTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e UNIVERSITY OF NEWCASTLE   (Australia)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

bipolar disorder; Health behaviour; obesity; physical health; schizophrenia

Indexed keywords

BIPOLAR DISORDER; CALORIC INTAKE; DIETARY INTAKE; EATING HABIT; EVALUATION STUDY; HUMAN; MENTAL PATIENT; META ANALYSIS; NUTRITIONAL ASSESSMENT; PSYCHOSIS; REVIEW; SODIUM INTAKE; SYSTEMATIC REVIEW; BODY WEIGHT; DIET; FACTUAL DATABASE; HEALTH BEHAVIOR; MENTAL DISEASE;

BODY WEIGHT; DATABASES, FACTUAL; DIET; HEALTH BEHAVIOR; HUMANS; MENTAL DISORDERS;

EID: 85064811981     PISSN: 00071250     EISSN: 14721465     Source Type: Journal    
DOI: 10.1192/bjp.2019.20     Document Type: Review

References (100)

1. Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry 2015; 72: 334-41.
2. Thornicroft G. Physical health disparities and mental illness: The scandal of premature mortality. Br J Psychiatry 2011; 199: 441-2.
3. Correll CU, Solmi M, Veronese N, Bortolato B, Rosson S, Santonastaso P, et al. Prevalence, incidence andmortality fromcardiovascular disease in patients with pooled and specific severe mental illness: A large?scale meta?analysis of 3, 211, 768 patients and 113, 383, 368 controls.World Psychiatry 2017; 16: 163-80.
4. Gakidou E, Afshin A, Abajobir AA, Abate KH, Abbafati C, Abbas KM, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016. Lancet 2017; 390: 1345-422.
5. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-23.
6. Galletly CA, Castle D, Dark F, Humberstone V, Jablensky A, Killacky E, et al. Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder. Aust N Z J Psychiatry 2016; 50: 1-117.
7. Álvarez-Jiménez M, González-Blanch C, Crespo-Facorro B, Hetrick S, Rodriguez-Sánchez JM, Pérez-Iglasias R, et al. Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders. CNS Drugs 2008; 22: 547-62.
8. Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, Malhotra AK. Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. JAMA 2009; 302: 1765-73.
9. Vancampfort D, Stubbs B, Mitchell AJ, De Hert M, Wampers M, Ward PB, et al. Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta?analysis. World Psychiatry 2015; 14: 339-47.
10. Elman I, Borsook D, Lukas SE. Food intake and reward mechanisms in patients with schizophrenia: Implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006; 31: 2091-120.
11. Blouin M, Tremblay A, Jalbert ME, Venables H, Bouchard RH, Roy MA, et al. Adiposity and eating behaviors in patients under second generation antipsychotics. Obesity 2008; 16: 1780-7.
12. Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: A systematic review. J Psychiatr Res 2013; 47: 197-207.
13. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Metaanalysis of observational studies in epidemiology: A proposal for reporting. JAMA 2000; 283: 2008-12.
14. Moher D, Liberati A, Tetzlaff J, Altman TG, Altman D, Antes G, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med 2009; 151: 264-9.
15. Academy of Nutrition and Dietetics. Evidence Analysis Manual: Steps in the Academy Evidence Analysis Process. Evidence Analysis Library, 2016.
16. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. Comprehensive Meta-Analysis Version 2: 104. Biostat, 2005.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
18. Orwin RG. A fail-safe N for effect size in meta-analysis. J Educ Stat 1983; 8: 157-9.
19. Adolfo AB, AhnAllen CG, Tidey JW. Effects of smoking cues on caffeine urges in heavy smokers and caffeine consumers with and without schizophrenia. Schizophr Res 2009; 107: 192-7.
20. Amani R. Is dietary pattern of schizophrenia patients different from healthy subjects? BMC Psychiatry 2007; 7: 15.
21. Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, McColl L, McNiven J. Psychotic disorders, eating habits, and physical activity: Who is ready for lifestyle changes? Psychiatr Serv 2007; 58: 233-9.
22. Arrojo-Romero M, Armas Barbazán C, López-Moriñigo JD, Ramos-Rios R, Gurpegui M, Martinez-Ortega JM, et al. Caffeine consumption in a long-term psychiatric hospital: Tobacco smoking may explain in large part the apparent association between schizophrenia and caffeine use. Schizophr Res 2015; 164: 234-41.
23. Baethge C, Tondo L, Lepri B, Baldessarini RJ. Coffee and cigarette use: Association with suicidal acts in 352 Sardinian bipolar disorder patients. Bipolar Disord 2009; 11: 494-503.
24. Bly MJ, Taylor SF, Dalack G, Pop-Busui R, Burghardt KJ, Evans SJ, et al. Metabolic syndrome in bipolar disorder and schizophrenia: Dietary and lifestyle factors compared to the general population. Bipolar Disord 2014; 16: 277-88.
25. Bobes J, Arango C, Garcia-Garcia M, Rejas J. Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: An analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort. Schizophr Res 2010; 119: 101-9.
26. Brown S, Birtwistle J, Roe L, Thompson C. The unhealthy lifestyle of people with schizophrenia. Psychol Med 1999; 29: 697-701.
27. Chang YW, Assari S, Prossin AR, Stertz L, McInnis MG, Evans SG. Bipolar disorder moderates associations between linoleic acid and markers of inflammation. J Psychiatr Res 2017; 85: 29-36.
28. Clayton EH, Hanstock TL, Hirneth SJ, Kable CJ, Garg ML, Hazell PL. Long-chain omega-3 polyunsaturated fatty acids in the blood of children and adolescents with juvenile bipolar disorder. Lipids 2008; 43: 1031-8.
29. Ellingrod VL, Taylor SF, Brook RD, Evans SJ, Zölliner SK, Grove TB, et al. Dietary, lifestyle and pharmacogenetic factors associated with arteriole endothelialdependent vasodilatation in schizophrenia patients treated with atypical antipsychotics (AAPs). Schizophr Res 2011; 130: 20-6.
30. Elmslie JL, Mann JI, Silverstone JT, Williams SM, Romans SE. Determinants of overweight and obesity in patients with bipolar disorder. J Clin Psychiatry 2001; 62: 486-91.
31. Evans SJ, Assari S, Harrington GJ, Chang YW, Burant CF, McInnis MG. Plasma linoleic acid partially mediates the association of bipolar disorder on selfreported mental health scales. J Psychiatr Res 2015; 68: 61-7.
32. Evans SJ, Ringrose RN, Harrington GJ, Mancuso P, Burant CF, McInnis MG. Dietary intake and plasma metabolomic analysis of polyunsaturated fatty acids in bipolar subjects reveal dysregulation of linoleic acid metabolism. J Psychiatr Res 2014; 57: 58-64.
33. Fawzi MH, Fawzi MM, Said NS, Fawzi MM, Fouad AA, Abdel-Moety H. Effect of Ramadan fasting on anthropometric, metabolic, inflammatory and psychopathology status of Egyptian male patients with schizophrenia. Psychiatry Res 2015; 225: 501-8.
34. Fusar-Poli P, De Marco L, Cavallin F, Bertorello A, Nicolasi M, Politi P. Lifestyles and cardiovascular risk in individuals with functional psychoses. Perspect Psychiatr Care 2009; 45: 87-99.
35. Gothelf D, Falk B, Singer P, Kairi M, Philliip M, Zigel L, et al. Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine. Am J Psychiatry 2002; 159: 1055-7.
36. Gupta A, Craig TK. Diet, smoking and cardiovascular risk in schizophrenia in high and low care supported housing. Epidemiol Psichiatr Soc 2009; 18: 200-7.
37. Gurpegui M, Aguilar MC, Martinez-Ortega JM, Diaz FJ, de Leon J. Caffeine intake in outpatients with schizophrenia. Schizophr Bull 2004; 30: 935-45.
38. Gurpegui M, Aguilar MC, Martinez-Ortega JM, Jurado D, Diaz FJ, Quintana HM, et al. Fewer but heavier caffeine consumers in schizophrenia: A case-control study. Schizophr Res 2006; 86: 276-83.
39. Hahn LA, Galletly CA, Foley DL, Mackinnon A, Watts GF, Castle DJ, et al. Inadequate fruit and vegetable intake in people with psychosis. Aust N Z J Psychiatry 2014; 48: 1025-35.
40. Hamera E, Schneider JK, Deviney S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. J Nerv Ment Dis 1995; 183: 559-65.
41. Hardy S, Gray R. The secret food diary of a person diagnosed with schizophrenia. J Psychiatr Ment Health Nurs 2012; 19: 603-9.
42. Haruyuki ITO, Kumagai T, Kimura M, Kolke S, Shimizu T. Dietary intake in body mass index differences in community-based Japanese patients with schizophrenia. Iranian J Public Health 2015; 44: 639-45.
43. Heald A, Pendlebury J, Anderson S, Narayan V, Guy M, Gibson M, et al. Lifestyle factors and the metabolic syndrome in schizophrenia: A cross-sectional study. Ann Gen Psychiatry 2017; 16: 12.
44. Henderson DC, Borba CP, Daley TB, Boxill R, Nguyen DD, Culhane MA, et al. Dietary intake profile of patients with schizophrenia. Ann Clin Psychiatry 2006; 18: 99-105.
45. Henderson DC, Cagliero E, Copeland PM, Borba CP, Evins E, Hayden D, et al. Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: A frequently sampled intravenous glucose tolerance test and minimal model analysis. Arch Gen Psychiatry 2005; 62: 19-28.
46. Jacka FN, Pasco JA, Mykletun A, Williams LJ, Nicholson GC, Kotowicz MA, et al. Diet quality in bipolar disorder in a population-based sample of women. J Affect Disord 2011; 129: 332-7.
47. Jahrami HA, Faris MAE, Saif ZQ, Hammad LH. Assessing dietary and lifestyle risk factors and their associations with disease comorbidities among patients with schizophrenia: A case-control study from Bahrain. Asian J Psychiatr 2017; 28: 115-23.
48. Kilbourne AM, Rofey DL, McCarthy JF, Post EP, Welsh D, Blow FC. Nutrition and exercise behavior among patients with bipolar disorder. Bipolar Disord 2007; 9: 443-52.
49. Kilian R, Becker T, Krüger L, Schmid S, Frasch K. Health behavior in psychiatric in-patients compared with a German general population sample. Acta Psychiatr Scand 2006; 114: 242-8.
50. Konarzewska B, Stefa?ska E, Wendolowicz A, Cwalina U, Golonko A, Malus A, et al. Visceral obesity in normal-weight patients suffering from chronic schizophrenia. BMC Psychiatry 2014; 14: 35.
51. Manzanares N, Monseny R, Ortega L, Montalvo I, Franch J, Gutliérrez-Zotes A, et al. Unhealthy lifestyle in early psychoses: The role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2014; 39: 1-10.
52. McCreadie RG, Scottish Schizophrenia Lifestyle Group. Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. Br J Psychiatry 2003; 183: 534-9.
53. Mucheru D, Hanlon MC, Campbell LE, McEvoy M, MacDonald-Wicks L. Social dysfunction and diet outcomes in people with psychosis. Nutrients 2017; 9: 80.
54. Nenke MA, Hahn LA, Thompson CH, Liu D, Galletly CA. Psychosis and cardiovascular disease: Is diet the missing link? Schizophr Res 2015; 161: 465-70.
55. Nunes D, Eskinazi B, Cambolm Rockett F, Delgado VB, Schwelgert Perry ID. Nutritional status, food intake and cardiovascular disease risk in individuals with schizophrenia in southern Brazil: A case-control study. Rev Psiquiatr Salud Ment 2014; 7: 72-9.
56. Osborn DP, Nazareth I, King MB. Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 787-93.
57. Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: A cross-sectional study. Compr Psychiatry 2012; 53: 1028-33.
58. Roick C, FritzWieacker A, Matschinger H, Heider D, Schindler J, Riedel-Heller S, et al. Health habits of patients with schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 268-76.
59. Ryan MC, Flanagan S, Kinsella U, Keeling F, Thakore JH. The effects of atypical antipsychotics on visceral fat distribution in first episode, drug-naive patients with schizophrenia. Life Sci 2004; 74: 1999-2008.
60. Ryan MCM, Collins P, Thakore JH. Impaired fasting glucose tolerance in firstepisode, drug-naive patients with schizophrenia. Am J Psychiatry 2003; 160: 284-9.
61. Saarni S, Saarni SI, Fogelholm M, Fogelholm M, Heliövaara M, Perälä J, Suvisaari J, et al. Body composition in psychotic disorders: A general population survey. Psychol Med 2009; 39: 801-10.
62. Samele C, Patel M, Boydell J, Leese M, Wessely S, Murray R. Physical illness and lifestyle risk factors in people with their first presentation of psychosis. Soc Psychiatry Psychiatr Epidemiol 2007; 42: 117-24.
63. Simonelli-Munõz AJ, Fortea MI, Salorio P, Gallego-Gomez JI, Sánchez-Bautista S, Balanza S. Dietary habits of patients with schizophrenia: A selfreported questionnaire survey. Int J Ment Health Nurs 2012; 21: 220-8.
64. Stokes C, Peet M. Dietary sugar and polyunsaturated fatty acid consumption as predictors of severity of schizophrenia symptoms. Nutr Neurosci 2004; 7: 247-9.
65. Strassnig M, Singh Brar J, Ganguli R. Nutritional assessment of patients with schizophrenia: A preliminary study. Schizophr Bull 2003; 29: 393-7.
66. Strassnig M, Singh Brar J, Ganguli R. Increased caffeine and nicotine consumption in community-dwelling patients with schizophrenia. Schizophr Res 2006; 86: 269-75.
67. Strassnig M, Singh Brar J, Ganguli R. Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia. Schizophr Res 2005; 76: 343-51.
68. Sugawara N, Yasui-Furukori N, Sato Y, Saito M, Furukori H, Nakagami T, et al. Dietary patterns are associated with obesity in Japanese patients with schizophrenia. BMC Psychiatry 2014; 14: 184.
69. Sugawara N, Yasui-Furukori N, Yamazaki M, Shimoda K, Mori T, Sugai T, et al. Attitudes toward metabolic adverse events among patients with schizophrenia in Japan. Neuropsychiatr Dis Treat 2016; 12: 427-36.
70. Suvisaari JM, Saarni SI, Perälä J, Suvisaari JV, Härkänen T, Lönnqvist J, et al. Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey. J Clin Psychiatry 2007; 68: 1045-55.
71. Treuer T, Hoffman VP, Chen AK, Irimia V, Ocampo M, Wang G, et al. Factors associated with weight gain during olanzapine treatment in patients with schizophrenia or bipolar disorder: Results from a six-month prospective, multinational, observational study. World J Biol Psychiatry 2009; 10: 729-40.
72. Tsuruga K, Sugawara N, Sato Y, Saito M, Furukori H, Nakagami T, et al. Dietary patterns and schizophrenia: A comparison with healthy controls. Neuropsychiatr Dis Treat 2015; 11: 1115-20.
73. Wallace B, Tennant C. Nutrition and obesity in the chronic mentally ill. Aust N Z J Psychiatry 1998; 32: 82-5.
74. Williamson K, Kilner K, Clibbens N. A comparison of the nutrient intake of a community-dwelling first-episode psychosis cohort, aged 19-64 years, with data from the UK population. J Nutr Sci 2015; 4: E28.
75. Winstead DK. Coffee consumption among psychiatric inpatients. Am J Psychiatry 1976; 133: 1447-50.
76. Noguchi R, Hiraoka M, Watanabe Y, Kagawa Y. Relationship between dietary patterns and depressive symptoms: Difference by gender, and unipolar and bipolar depression. J Nutr Sci Vitaminol 2013; 59: 115-22.
77. Archie SM, Goldberg JO, Akhtar-Danesh N, Landeen J, McColl L, McNiven J. Psychotic disorders, eating habits, and physical activity: Who is ready for lifestyle changes? Psychiatr Serv 2007; 58: 233-9.
78. Duffey KJ, Popkin BM. Energy density, portion size, and eating occasions: Contributions to increased energy intake in the United States, 1977-2006. PLoS Med 2011; 8: E1001050.
79. Appel LJ, Frohlich ED, Hall JE, Pearson TA, Sacco RL, Seals DR, et al. The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: A call to action from the American Heart Association. Circulation 2011; 123: 1138-43.
80. Vancampfort D, Firth J, Schuch FB, Rosenbaum S, Mugisha J, Hallgren M, et al. Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: A global systematic review and meta?analysis. World Psychiatry 2017; 16: 308-15.
81. Vancampfort D, Rosenbaum S, Schuch FB, et al. Cardiorespiratory fitness in severe mental illness: A systematic review and meta-analysis. Sports Med 2017; 47: 343-52.
82. Hall KD, Heymsfield SB, Kemnitz JW, Klein S, Schoeller DA, Speakman JR. Energy balance and its components: Implications for body weight regulation. Am J Clin Nutr 2012; 95: 989-94.
83. Werneke U, Taylor D, Sanders TAB. Behavioral interventions for antipsychotic induced appetite changes. Curr Psychiatry Rep 2013; 15: 347.
84. Lett TA, Wallace TJ, Chowdhury NI, Tiwari AK, Kennedy JL, Müller DJ. Pharmacogenetics of antipsychotic-induced weight gain: Review and clinical implications. Mol Psychiatry 2012; 17: 242-66.
85. Reynolds GP, Kirk SL. Metabolic side effects of antipsychotic drug treatment-pharmacological mechanisms. Pharmacol Ther 2010; 125: 169-79.
86. Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu K, De Hert M. Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-a systematic review and meta-analysis. Schizophr Bull 2011; 39: 306-18.
87. Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, et al. Nutritional deficiencies and clinical correlates in first-episode psychosis: A systematic review and meta-analysis. Schizophr Bull 2018; 44: 1275-92.
88. Burrows TL, Williams R, Rollo M, Wood L, Garg ML, Jensen M, et al. Plasma carotenoid levels as biomarkers of dietary carotenoid consumption: A systematic review of the validation studies. J Nutr IntermedMetab, 2015; 2: 15-64.
89. Hill RJ, Davies PSW. The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001; 85: 415-30.
90. Lally J, Ajnakina O, Stubbs B, Cullinane M, Murphy KC, Gaughran F, et al. Remission and recovery from first-episode psychosis in adults: Systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry, 2017; 211: 350-8.
91. Fountaine RJ, Taylor AE, Mancuso JP, Greenway FL, Byerley LO, Smith SR, et al. Increased food intake and energy expenditure following administration of olanzapine to healthy men. Obesity 2010; 18: 1646-51.
92. Teasdale SB, Ward PB, Rosenbaum S, Samaras K, Stubbs B. Solving a weighty problem: Systematic review and meta-analysis of nutrition interventions in severe mental illness. Br J Psychiatry 2017; 210: 110-8.
93. Quirk SE, Williams LJ, O'Neil A, Pasco JA, Jacka FN, Housden S, et al. The association between diet quality, dietary patterns and depression in adults: A systematic review. BMC Psychiatry 2013; 13: 175.
94. Jacka FN, O'Neil A, Opie R, Itsiopoulos C, Cotton S, Mohebbi M, et al. A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES'trial). BMC Med 2017; 15: 23.
95. Opie RS, O'Neil A, Jacka FN, Pizzinga J, Itsiopoulos C. A modified Mediterranean dietary intervention for adults with major depression: Dietary protocol and feasibility data from the SMILES trial. Nutr Neurosci 2018; 21: 487-501.
96. Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy The PATH Study. Neurology 2012; 79: 1019-26.
97. Jacka FN, Cherbuin N, Anstey KJ, Sachdev P, Butterworth P. Western diet is associated with a smaller hippocampus: A longitudinal investigation. BMC Med 2015; 13: 215.
98. Psaltopoulou T, Sergentanis TN, Panagiotakos DB, Sergentanis IN, Kosti R, Scarmeas N. Mediterranean diet, stroke, cognitive impairment, and depression: A meta?analysis. Ann Neurol 2013; 74: 580-91.
99. Shim JS, Oh K, Kim HC. Dietary assessment methods in epidemiologic studies. Epidemiol Health 2014; 36: E2014009.
100. Lachat C, Hawwash D, Ockè MC, Berg C, Forsum E, Hörnell A, et al. Strengthening the Reporting of Observational Studies in Epidemiology-nutritional epidemiology (STROBE?nut): An extension of the STROBE statement. Nutr Bull 2016; 41: 240-51.